University of Texas -MD Anderson Cancer Center, 1515 Holcombe Blvd.

1515 Holcombe Boulevard
Houston, Texas 77030

We've found

1 trials

at this facility

An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Houston, TX

Use our guide to learn which trials are right for you!